Dr. Michael J. Reardon and I discuss: 5-year Outcomes After Transcatheter Or Surgical Aortic Valve Replacement In Low-risk Patients With Aortic Stenosis March 30, 2025 Disclosures: TBD
Dr. and Rajesh Kharbanda I discuss: Routine Cerebral Embolic Protection In Transcatheter Aortic Valve Implantation: The British Heart Foundation (BHF) PROTECT-TAVI Trial March 30, 2025 Disclosures: TBD
Dr. Stefan D. Anker and I discuss: Ferric Carboxymaltose Assessment Of Morbidity And Mortality In Patients With Iron Deficiency And Chronic Heart Failure (FAIR-HF2) Trial March 30, 2025 Disclosures: TBD
Dr. Roland Van Kimmenade and I discuss: Liberal Fluid Intake Versus Fluid Restriction In Chronic Heart Failure March 30, 2025 Disclosures: TBD
Dr. Sergio Raposeiras Roubin and I Discuss: Dapagliflozin In Patients Undergoing Transcatheter Aortic Valve Implantantion March 29, 2025 Disclosures: TBD Copyright NEJM
Dr. Antonius Buescher and I discuss: Development And External Validation Of A Deep Learning Electrocardiogram Model For Risk Stratification Of Coronary Revascularization Need In The Emergency Department March 29, 2025 Disclosures: TBD
Dr. Luke Laffin and I discuss: Efficacy Of Lorundrostat, A Novel Aldosterone Synthase Inhibitor, In Patients With Uncontrolled Hypertension On A Standardized Antihypertensive Medication Regimen March 29, 2025 Disclosures: TBD
Dr. Hyo-Soo Kim and I discussed the HOST-BR trial on optimal DAPT duration and thrombosis-bleeding balance in ACS patients. 3-month DAPT reduced thrombosis vs. 1-month in high bleeding risk, and reduced bleeding vs. 12-month in low-risk patients March 29, 2025 Disclosures: TBD
Dr. Keyvan Karkouti and I discussed the FARES-II trial. PCC is superior to FP for hemostasis in managing excessive bleeding among cardiac surgery ptS with coagulopathy. March 29, 2025 Disclosures: TBD
Dr. Marc Bonaca and I discussed the STRIDE trial. Semaglutide improves functional outcomes in DM pts with symptomatic PAD, addressing a critical unmet need. March 29, 2025 Disclosures: TBD
